Table 2. Comparison of baseline characteristics between the two-study groups.
Baseline | Pre-MDT (N = 18) | Post-MDT (N = 10) | P |
---|---|---|---|
Age (years) | 36 ± 11 | 34 ± 28 | 0.88 |
Sex, M/F, n (%) | 6(33) / 12(67) | 4(40) / 6(60) | 0.72 |
Hb (g/dL) | 9.0 ± 2.1 | 10.8 ± 2.3 | 0.06 |
Platelets (1000/μL) | 44600(23000–84000) | 39900(19600–84000) | 0.89 |
LDH (U/L) | 1994 ± 1425 | 2170 ± 1495 | 0.77 |
Schistocytes (Yes/No), n (%) | 12(67) / 6(33) | 9(90) / 1(10) | 0.36 |
Schistocytes per field | 3(2–8) | 4(2–5) | 0.60 |
HD-ad (yes/no), n (%) | 10(56) / 8(44) | 8(80) / 2(20) | 0.19 |
ICU-ad, (yes/no), n (%) | 9(50) / 9(50) | 9(90) / 1(10) | 0.03 |
Hb, hemoglobin; HD-ad, hemodialysis at admission time; ICU-ad: admission at intensive care unit, LDH: lactate dehydrogenase; MDT: multidisciplinary team